You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Litigation Details for INDIVIOR INC. v. ALVOGEN PINE BROOK, INC. (D.N.J. 2017)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in INDIVIOR INC. v. ALVOGEN PINE BROOK, INC.
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .

Details for INDIVIOR INC. v. ALVOGEN PINE BROOK, INC. (D.N.J. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2019-02-26 121 of Dismissal of Claims Relating to U.S. Patent No. 9,855,221. etc. Signed by Judge Kevin McNulty on 2…14 September 2017 2:17-cv-07106 835 Patent - Abbreviated New Drug Application(ANDA) Defendant External link to document
2019-11-05 215 film is also covered by Patent No. 8,603,514 (“the ‘514 Patent”). The ‘514 Patent shares the same specification…7111 at DE 250-1). “514 Patent” = United States Patent No. 8,603,514, P1. Ex. C (Dkt. No. 7106 at… Alvogen. The patents-in-suit are Patent Nos. 9,931,305 (“the ‘305 Patent”), issued to Aquestive…Aquestive. The patent for that film, the ‘514 Patent, was issued on December 10, 2013.2 (‘514 Patent at [45j…films” in the ‘514 Patent. Id. at 1027. In reviewing the ‘305 Patent and the ‘514 Patent, the Federal Circuit External link to document
2019-11-19 217 obtained U.S. Patent Nos. 9,931,305 and 9,687,454 (the “’305 patent” and the “’454 patent,” respectively…events of the above motions. Following a related patent infringement litigation in the District of Delaware…respectively) and subsequently asserted patent infringement claims against DRL and Alvogen in various cases in…Indivior was unlikely to succeed on the merits of its patent infringement claim. Indivior Inc. v. Dr. Reddy’…judgment and forfeiture of various trademarks, patents, assets and receivables. III. DISCUSSION External link to document
2018-02-06 23 United States Patent Nos. 9,687,454 (“the ’454 patent”) and 9,855,221 (“the ’221 patent”) (collectively…’221 patent, and Plaintiff Indivior is an exclusive licensee of the ’221 patent. The ’221 patent, entitled…is an action for patent infringement arising under the Food and Drug Laws and Patent Laws of the United…THE PATENTS-IN-SUIT 11. Plaintiff Indivior UK is the lawful owner of the ’454 patent, and… is an exclusive licensee of the ’454 patent. The ’454 patent, entitled “Sublingual and Buccal Film External link to document
2020-01-09 240 Plaintiffs' Claims of Infringement of U.S. Patent No. 9,931,305, etc. Signed by Judge Kevin McNulty on 1…14 September 2017 2:17-cv-07106 835 Patent - Abbreviated New Drug Application(ANDA) Defendant External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.